Online Pre-Screening Survey |
Hello! Thank you for your interest in participating in our valuable research.
At the Human Addiction Psychopharmacology Lab, we recruit participants for several research studies that may have different eligibility criteria (for example, age, drug use history, current drug use, biological sex, etc.). Studies are conducted at the UIC Psychiatric Institute (1601 W Taylor Street in Chicago) and involve 2 or more trips to the lab. Many of our studies involve the consumption of drugs and alcohol.
To see which, if any, of our studies you may qualify to participate in, you will need to provide us with some preliminary information through this online survey. This online survey is completely confidential and is not revealed to any other persons. You will not be compensated for completing this questionnaire.
Once you have completed the confidential questionnaire, we will review your responses and email you information about any studies you may qualify for. Please note that review of your survey may take up to one week, so if you have already filled out a questionnaire, please DO NOT fill out another questionnaire. Instead, please email us at uichappylab@gmail.com to see where you are in the recruitment process.
To ensure that you get our emails in case you do qualify for a study, please add our email, uichappylab@gmail.com, to your approved list.
Again, all the information you disclose on the questionnaire is confidential. We will also contact you if your information does NOT match the eligibility criteria for our current studies, but it is not in our policy to disclose why. If you do not qualify for a study, you may opt to remove your data from our files or remain in our database so that we may contact you for any new studies that you may potentially qualify for.
If you meet the basic criteria, you will be invited for an in-person visit at the laboratory to complete a screening interview (lasting 1h) where we will obtain more detailed information about your medical and drug use history. You may decline to answer a question or decline participation at any time. At this screening visit, we will also obtain an electrocardiogram (EKG) which is a harmless, painless test that detects the heart’s electrical activity by attaching leads to your chest.
Risks associated with the screening process involve a potential loss of confidentiality and minor risks associated with the EKG such as a rash where the leads are attached to your chest using sticky pads. Potential benefits of the screening process include discovery of a previously undiagnosed medical or psychiatric condition
Principal Investigator: Dr. Emma Childs
IRB Protocol Number: 2020-0706
Approval Date: March 30, 2022